Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2005 | 1 |
2007 | 1 |
2025 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligand.
Cancer Res. 2007 Dec 15;67(24):11951-8. doi: 10.1158/0008-5472.CAN-07-0780.
Cancer Res. 2007.
PMID: 18089826
Membrane Fas ligand activates innate immunity and terminates ocular immune privilege.
Gregory MS, Repp AC, Holhbaum AM, Saff RR, Marshak-Rothstein A, Ksander BR.
Gregory MS, et al.
J Immunol. 2002 Sep 1;169(5):2727-35. doi: 10.4049/jimmunol.169.5.2727.
J Immunol. 2002.
PMID: 12193747
Item in Clipboard
A novel treatment for ocular tumors using membrane FasL vesicles to activate innate immunity and terminate immune privilege.
Gregory MS, Koh S, Huang E, Saff RR, Marshak-Rothstein A, Mukai S, Ksander BR.
Gregory MS, et al.
Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2495-502. doi: 10.1167/iovs.05-0048.
Invest Ophthalmol Vis Sci. 2005.
PMID: 15980241
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.